GlaxoSmithKline has agreed to support the infrastructure and staff of a new research body

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1326, 2002-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An amended lawsuit has been filed against pharmaceutical giant GlaxoSmithKline

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 388, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline's candidate paediatric pneumococcal vaccine GSK 1024850A [Synflorix] has the potential to offer increased protection

Inpharma, Vol. 1, Iss. 1643, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline (GSK), in consultation with Health Canada, has issued a precautionary recall of one lot of Infanrix Hexa

Reactions Weekly, Vol. 1, Iss. 1428, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Health Canada has approved GlaxoSmithKline's controlled-release formulation of paroxetine

Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Lamivudine/abacavir [Kivexa; GlaxoSmithKline] has been launched in the UK and Germany

Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite